Rationale for cholesteryl ester transfer protein inhibition.
about
Cholesterol crystals and inflammationRegression of atherosclerosis: insights from animal and clinical studiesPostprandial changes in high density lipoproteins in rats subjected to gavage administration of virgin olive oilHarnessing publicly available genetic data to prioritize lipid modifying therapeutic targets for prevention of coronary heart disease based on dysglycemic risk.CETP inhibitors and cardiovascular disease: Time to think again.Functional characterization of newly-discovered mutations in human SR-BIReview of the quantitative analysis of cholesteryl ester transfer protein inhibitors.MicroRNA control of high-density lipoprotein metabolism and functionAnacetrapib lowers LDL by increasing ApoB clearance in mildly hypercholesterolemic subjects.Effect of hepatic or renal impairment on the pharmacokinetics of evacetrapibSingle nucleotide polymorphisms in CETP, SLC46A1, SLC19A1, CD36, BCMO1, APOA5, and ABCA1 are significant predictors of plasma HDL in healthy adultsFuture of cholesteryl ester transfer protein (CETP) inhibitors: a pharmacological perspective.Multi-locus candidate gene analyses of lipid levels in a pediatric Turkish cohort: lessons learned on LPL, CETP, LIPC, ABCA1, and SHBGAbsolute bioavailability of evacetrapib in healthy subjects determined by simultaneous administration of oral evacetrapib and intravenous [(13) C8 ]-evacetrapib as a tracer.Impact of Increased Gastric pH on the Pharmacokinetics of Evacetrapib in Healthy Subjects.Effects of a purified krill oil phospholipid rich in long-chain omega-3 fatty acids on cardiovascular disease risk factors in non-human primates with naturally occurring diabetes type-2 and dyslipidemia.Functional genomics of the human high-density lipoprotein receptor scavenger receptor BI: an old dog with new tricks.Lipoprotein metabolism, dyslipidemia, and nonalcoholic fatty liver disease.LDL, HDL, VLDL, and CVD Prevention: Lessons from Genetics?Effects of native and myeloperoxidase-modified apolipoprotein a-I on reverse cholesterol transport and atherosclerosis in mice.Mass spectrometry meets the challenge of understanding the complexity of the lipoproteome: recent findings regarding proteins involved in dyslipidemia and cardiovascular disease.The role of HDL in plaque stabilization and regression: basic mechanisms and clinical implications.HDL and cardiovascular risk: time to call the plumber?Killing two birds with one stone, maybe: CETP inhibition increases both high-density lipoprotein levels and insulin secretion.A coding variant in SR-BI (I179N) significantly increases atherosclerosis in mice.HDL--is it too big to fail?
P2860
Q27024737-444D7CCB-B574-4011-A36D-0914E31FE208Q27028112-9F0D1696-2F0E-4414-B527-75E492750B11Q28569962-360FE69D-4870-4761-BD07-C267EE203359Q31053398-10CA5946-C4F7-482B-BA4E-99F1EDA318BCQ34109100-AAC78D8E-406D-4757-AEB5-49DBF5C89360Q34429737-634A604B-D328-45F7-8805-5BD0383BAEB8Q34708105-96BAB3A6-8B2C-44FC-8E19-65594888D55BQ35200081-A67FEC4C-0F01-4878-B3FB-1FE3E263A6ADQ35836143-13906D7A-D23B-4C98-892C-46A8DBD42499Q36805125-99BABD42-0EAA-45C3-82B9-CA56B216C85AQ36843378-F2F33676-9515-469A-948F-8B6813AA035CQ37038670-0264D005-090D-4CD1-B03B-911B9FAC281EQ37334692-DAEA7CF0-187F-4600-99CA-D48550A64CB5Q37340474-555DED69-8791-43D5-880E-0EC560166492Q37412777-FF399943-A6BD-466E-9FE4-257C19CBA07FQ37589150-F1C84A95-23AB-42A3-85AB-580090DCD912Q37667665-448ADD94-2490-41EA-9FAA-D03ACD58588BQ37705810-ACCA4EE5-23FF-4866-85F2-04754C2890E3Q38511045-FF0E3A69-F967-4267-AB4E-1F4C9DB60892Q38532483-CEDC72C6-ED56-4A0D-91E6-3CAA0D96336CQ38577853-BE37F612-A653-4F91-B2D0-6B90A86D067AQ38896299-B667C622-73D8-494F-B3B1-EABAD550FDCEQ39620597-71BAB136-7A71-4F56-B33D-B28FBFE696DBQ42410902-E4D52279-75CE-4300-ADB3-36F9DA41450FQ43751225-8A0829CB-D005-48B9-A231-0453F4E5BE98Q46866176-E38430ED-095E-474C-AC13-8145CF349A1B
P2860
Rationale for cholesteryl ester transfer protein inhibition.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Rationale for cholesteryl ester transfer protein inhibition.
@en
type
label
Rationale for cholesteryl ester transfer protein inhibition.
@en
prefLabel
Rationale for cholesteryl ester transfer protein inhibition.
@en
P2860
P1476
Rationale for cholesteryl ester transfer protein inhibition.
@en
P2093
Bernd Hewing
P2860
P304
P356
10.1097/MOL.0B013E328353EF1D
P577
2012-08-01T00:00:00Z